Literature DB >> 19320370

State-based surveillance to determine trends in meningococcal disease.

Carmen Clarke1, Sue Mallonee.   

Abstract

OBJECTIVES: Meningococcal disease (MD), is a leading cause of meningitis in the U.S. The purpose of this study was to determine the epidemiology of MD in Oklahoma, including trends, high-risk populations, and outcomes.
METHODS: Cases from the statewide passive reporting system with disease onset between 1988 and 2004 were included; 2002-2004 cases were linked to hospital discharge data. We performed a multivariate logistic regression of variables predicting death.
RESULTS: There were 545 total cases (mean annual incidence rate 1.0/100,000); 13% died. Rates were highest for children younger than 2 years of age; black males had rates two times higher than the state rate and a different age distribution than other race-gender groups. Mean length of hospital stay was 12 days and mean charges were $37,724. For every 10 years of age, the risk of death increased 13% (adjusted odds ratio 1.13, 95% confidence interval [CI] 1.05, 1.22). People younger than age 40 who developed MD between October and February were 68% more likely to die than those who developed it in other months (rate ratio [RR] 1.68, 95% CI 1.39, 2.05); an increased risk of death during these months was not statistically significant in people aged 40 and older (RR 1.19, 95% CI 0.83, 1.69).
CONCLUSION: Using statewide public health surveillance data to characterize the epidemiology of MD is important to understand local trends and risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320370      PMCID: PMC2646485          DOI: 10.1177/003335490912400216

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  31 in total

1.  A 20-year ecological study of the temporal association between influenza and meningococcal disease.

Authors:  Elise Snitker Jensen; Søren Lundbye-Christensen; Susanne Samuelsson; Henrik Toft Sørensen; Henrik Carl Schønheyder
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Mortality in meningococcal disease.

Authors:  K Cartwright; J Strang; S Reilly; D White
Journal:  BMJ       Date:  1992-01-11

3.  Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis.

Authors:  P S Moore; J Hierholzer; W DeWitt; K Gouan; D Djoré; T Lippeveld; B Plikaytis; C V Broome
Journal:  JAMA       Date:  1990-09-12       Impact factor: 56.272

4.  Risk factors for meningococcal disease: a case control study in south west England.

Authors:  J M Stuart; K A Cartwright; J A Dawson; J Rickard; N D Noah
Journal:  Community Med       Date:  1988-05

5.  Influenza A and meningococcal disease.

Authors:  K A Cartwright; D M Jones; A J Smith; J M Stuart; E B Kaczmarski; S R Palmer
Journal:  Lancet       Date:  1991-08-31       Impact factor: 79.321

Review 6.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

7.  Smoking, the environment and meningococcal disease: a case control study.

Authors:  R E Stanwell-Smith; J M Stuart; A O Hughes; P Robinson; M B Griffin; K Cartwright
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

8.  Meningococcal disease and influenza-like syndrome: a new approach to an old question.

Authors:  B Hubert; L Watier; P Garnerin; S Richardson
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

9.  Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991.

Authors:  L A Jackson; J D Wenger
Journal:  MMWR CDC Surveill Summ       Date:  1993-06-04

10.  Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Authors:  Leah D Fletcher; Liesel Bernfield; Vicki Barniak; John E Farley; Alan Howell; Melissa Knauf; Peggy Ooi; Robert P Smith; Paige Weise; Mike Wetherell; Xiaoling Xie; Robert Zagursky; Ying Zhang; Gary W Zlotnick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  3 in total

1.  Costs of Invasive Meningococcal Disease: A Global Systematic Review.

Authors:  Bing Wang; Renee Santoreneos; Hossein Afzali; Lynne Giles; Helen Marshall
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

Review 2.  Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity.

Authors:  Mark R Cullen; Adina R Lemeshow; Leo J Russo; David M Barnes; Yaa Ababio; Aida Habtezion
Journal:  Healthcare (Basel)       Date:  2022-03-23

Review 3.  Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.

Authors:  Sandra Guedes; Isabelle Bertrand-Gerentes; Keith Evans; Florence Coste; Philipp Oster
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.